Metabolic and monetary costs of avoidable parenteral nutrition use

Elaine B. Trujillo, Lorraine S. Young, Glenn M. Chertow, Sheldon Randall, Traci Clemons, Danny O. Jacobs, Malcolm K. Robinson

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Background: We prospectively collected data on in patients receiving parenteral nutrition to determine the magnitude of potentially preventable metabolic and monetary costs associated with parenteral nutrition. Methods: Parenteral nutrition was prescribed by the treating physicians with optional consultation from a multidisciplinary metabolic support service. Days on parenteral nutrition, appropriateness of parenteral nutrition, metabolic complications, and avoidable parenteral nutrition charges were determined. Parenteral nutrition use was considered 'indicated' or 'not indicated' based on the American Society for Parenteral and Enteral Nutrition guidelines and 'preventable' if the gastrointestinal tract was functional but not accessed when possible. Results: Of the 209 parenteral nutrition starts, 62% were indicated, 23% were preventable, and 15% were not indicated. Parenteral nutrition starts were deemed indicated in 82% of instances in which a metabolic support service consult was obtained, compared with 56% in which a consultation was not obtained (p = .004). Hyperglycemia was the most common metabolic complication, with an overall incidence of 20%. Metabolic complications occurred less frequently in patients who received a metabolic support service consultation compared with patients who did not (34% vs 66% of parenteral nutrition days, respectively; p = .004). Parenteral nutrition use of ≤5 days duration was significantly less frequent among patients who received metabolic support service consultation (16% vs 35%; p = .002). Parenteral nutrition that was not indicated or preventable resulted in excess annualized patient charges of more than one half million dollars not accounting for charges related to treatment of potentially avoidable parenteral nutrition complications. Conclusions: This study illustrates that not-indicated and preventable parenteral nutrition initiation, short-term parenteral nutrition use, and metabolic complications are less likely when patients receive consultation by a multidisciplinary team with expertise in nutrition and metabolic support. Furthermore, the avoidance of inappropriate parenteral nutrition use translates into substantial cost savings.

Original languageEnglish (US)
Pages (from-to)109-113
Number of pages5
JournalJournal of Parenteral and Enteral Nutrition
Volume23
Issue number2
StatePublished - 1999
Externally publishedYes

Fingerprint

Parenteral Nutrition
parenteral feeding
Costs and Cost Analysis
Referral and Consultation
Cost Savings
cost effectiveness
hyperglycemia
physicians
Hyperglycemia
gastrointestinal system

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Food Science

Cite this

Trujillo, E. B., Young, L. S., Chertow, G. M., Randall, S., Clemons, T., Jacobs, D. O., & Robinson, M. K. (1999). Metabolic and monetary costs of avoidable parenteral nutrition use. Journal of Parenteral and Enteral Nutrition, 23(2), 109-113.

Metabolic and monetary costs of avoidable parenteral nutrition use. / Trujillo, Elaine B.; Young, Lorraine S.; Chertow, Glenn M.; Randall, Sheldon; Clemons, Traci; Jacobs, Danny O.; Robinson, Malcolm K.

In: Journal of Parenteral and Enteral Nutrition, Vol. 23, No. 2, 1999, p. 109-113.

Research output: Contribution to journalArticle

Trujillo, EB, Young, LS, Chertow, GM, Randall, S, Clemons, T, Jacobs, DO & Robinson, MK 1999, 'Metabolic and monetary costs of avoidable parenteral nutrition use', Journal of Parenteral and Enteral Nutrition, vol. 23, no. 2, pp. 109-113.
Trujillo EB, Young LS, Chertow GM, Randall S, Clemons T, Jacobs DO et al. Metabolic and monetary costs of avoidable parenteral nutrition use. Journal of Parenteral and Enteral Nutrition. 1999;23(2):109-113.
Trujillo, Elaine B. ; Young, Lorraine S. ; Chertow, Glenn M. ; Randall, Sheldon ; Clemons, Traci ; Jacobs, Danny O. ; Robinson, Malcolm K. / Metabolic and monetary costs of avoidable parenteral nutrition use. In: Journal of Parenteral and Enteral Nutrition. 1999 ; Vol. 23, No. 2. pp. 109-113.
@article{0999610073ab4d469d49326d3034db18,
title = "Metabolic and monetary costs of avoidable parenteral nutrition use",
abstract = "Background: We prospectively collected data on in patients receiving parenteral nutrition to determine the magnitude of potentially preventable metabolic and monetary costs associated with parenteral nutrition. Methods: Parenteral nutrition was prescribed by the treating physicians with optional consultation from a multidisciplinary metabolic support service. Days on parenteral nutrition, appropriateness of parenteral nutrition, metabolic complications, and avoidable parenteral nutrition charges were determined. Parenteral nutrition use was considered 'indicated' or 'not indicated' based on the American Society for Parenteral and Enteral Nutrition guidelines and 'preventable' if the gastrointestinal tract was functional but not accessed when possible. Results: Of the 209 parenteral nutrition starts, 62{\%} were indicated, 23{\%} were preventable, and 15{\%} were not indicated. Parenteral nutrition starts were deemed indicated in 82{\%} of instances in which a metabolic support service consult was obtained, compared with 56{\%} in which a consultation was not obtained (p = .004). Hyperglycemia was the most common metabolic complication, with an overall incidence of 20{\%}. Metabolic complications occurred less frequently in patients who received a metabolic support service consultation compared with patients who did not (34{\%} vs 66{\%} of parenteral nutrition days, respectively; p = .004). Parenteral nutrition use of ≤5 days duration was significantly less frequent among patients who received metabolic support service consultation (16{\%} vs 35{\%}; p = .002). Parenteral nutrition that was not indicated or preventable resulted in excess annualized patient charges of more than one half million dollars not accounting for charges related to treatment of potentially avoidable parenteral nutrition complications. Conclusions: This study illustrates that not-indicated and preventable parenteral nutrition initiation, short-term parenteral nutrition use, and metabolic complications are less likely when patients receive consultation by a multidisciplinary team with expertise in nutrition and metabolic support. Furthermore, the avoidance of inappropriate parenteral nutrition use translates into substantial cost savings.",
author = "Trujillo, {Elaine B.} and Young, {Lorraine S.} and Chertow, {Glenn M.} and Sheldon Randall and Traci Clemons and Jacobs, {Danny O.} and Robinson, {Malcolm K.}",
year = "1999",
language = "English (US)",
volume = "23",
pages = "109--113",
journal = "JPEN. Journal of parenteral and enteral nutrition",
issn = "0148-6071",
publisher = "SAGE Publications Inc.",
number = "2",

}

TY - JOUR

T1 - Metabolic and monetary costs of avoidable parenteral nutrition use

AU - Trujillo, Elaine B.

AU - Young, Lorraine S.

AU - Chertow, Glenn M.

AU - Randall, Sheldon

AU - Clemons, Traci

AU - Jacobs, Danny O.

AU - Robinson, Malcolm K.

PY - 1999

Y1 - 1999

N2 - Background: We prospectively collected data on in patients receiving parenteral nutrition to determine the magnitude of potentially preventable metabolic and monetary costs associated with parenteral nutrition. Methods: Parenteral nutrition was prescribed by the treating physicians with optional consultation from a multidisciplinary metabolic support service. Days on parenteral nutrition, appropriateness of parenteral nutrition, metabolic complications, and avoidable parenteral nutrition charges were determined. Parenteral nutrition use was considered 'indicated' or 'not indicated' based on the American Society for Parenteral and Enteral Nutrition guidelines and 'preventable' if the gastrointestinal tract was functional but not accessed when possible. Results: Of the 209 parenteral nutrition starts, 62% were indicated, 23% were preventable, and 15% were not indicated. Parenteral nutrition starts were deemed indicated in 82% of instances in which a metabolic support service consult was obtained, compared with 56% in which a consultation was not obtained (p = .004). Hyperglycemia was the most common metabolic complication, with an overall incidence of 20%. Metabolic complications occurred less frequently in patients who received a metabolic support service consultation compared with patients who did not (34% vs 66% of parenteral nutrition days, respectively; p = .004). Parenteral nutrition use of ≤5 days duration was significantly less frequent among patients who received metabolic support service consultation (16% vs 35%; p = .002). Parenteral nutrition that was not indicated or preventable resulted in excess annualized patient charges of more than one half million dollars not accounting for charges related to treatment of potentially avoidable parenteral nutrition complications. Conclusions: This study illustrates that not-indicated and preventable parenteral nutrition initiation, short-term parenteral nutrition use, and metabolic complications are less likely when patients receive consultation by a multidisciplinary team with expertise in nutrition and metabolic support. Furthermore, the avoidance of inappropriate parenteral nutrition use translates into substantial cost savings.

AB - Background: We prospectively collected data on in patients receiving parenteral nutrition to determine the magnitude of potentially preventable metabolic and monetary costs associated with parenteral nutrition. Methods: Parenteral nutrition was prescribed by the treating physicians with optional consultation from a multidisciplinary metabolic support service. Days on parenteral nutrition, appropriateness of parenteral nutrition, metabolic complications, and avoidable parenteral nutrition charges were determined. Parenteral nutrition use was considered 'indicated' or 'not indicated' based on the American Society for Parenteral and Enteral Nutrition guidelines and 'preventable' if the gastrointestinal tract was functional but not accessed when possible. Results: Of the 209 parenteral nutrition starts, 62% were indicated, 23% were preventable, and 15% were not indicated. Parenteral nutrition starts were deemed indicated in 82% of instances in which a metabolic support service consult was obtained, compared with 56% in which a consultation was not obtained (p = .004). Hyperglycemia was the most common metabolic complication, with an overall incidence of 20%. Metabolic complications occurred less frequently in patients who received a metabolic support service consultation compared with patients who did not (34% vs 66% of parenteral nutrition days, respectively; p = .004). Parenteral nutrition use of ≤5 days duration was significantly less frequent among patients who received metabolic support service consultation (16% vs 35%; p = .002). Parenteral nutrition that was not indicated or preventable resulted in excess annualized patient charges of more than one half million dollars not accounting for charges related to treatment of potentially avoidable parenteral nutrition complications. Conclusions: This study illustrates that not-indicated and preventable parenteral nutrition initiation, short-term parenteral nutrition use, and metabolic complications are less likely when patients receive consultation by a multidisciplinary team with expertise in nutrition and metabolic support. Furthermore, the avoidance of inappropriate parenteral nutrition use translates into substantial cost savings.

UR - http://www.scopus.com/inward/record.url?scp=0033041374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033041374&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 109

EP - 113

JO - JPEN. Journal of parenteral and enteral nutrition

JF - JPEN. Journal of parenteral and enteral nutrition

SN - 0148-6071

IS - 2

ER -